Patogènesi de les malalties neuronals autoimmunes
Publicacions destacades
-
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Gaig C; Compta Y; Heidbreder A; Marti MJ; Titulaer MJ;(...)Sabater L; Iranzo A; Cano JS; Dalmau J; Graus F .Referència:Neurology 2021.
-
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2
Landa, J; Guasp, M; Miguez-Cabello, F; Guimaraes, J; Mishima, T;(...)Gasull, X; Soto, D; Graus, F; Sabater, L; Dalmau, J.Referència:Annals Of Neurology 2021.
-
Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis
Guasp M; Giné-Servén E; Maudes E; Rosa-Justicia M; Martínez-Hernández E;(...)Saiz A; Graus F; Castro-Fornieles J; Parellada E; Dalmau J .Referència:Neurology 2021.
-
Placental transfer of NMDAR antibodies causes reversible alterations in mice
García-Serra A; Radosevic M; Pupak A; Brito V; Ríos J;(...)Pedreño M; Joubert B; Ginés S; Planagumà J; Dalmau J .Referència:Neurology-Neuroimmunology & Neuroinflammation 2021.
-
Sleep disorders in autoimmune encephalitis
Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J;Referència:Lancet Neurology 2020.
-
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis
Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E;(...)Quirk M; Dai J; Gasull X; Lewis M; Dalmau J .Referència:Brain 2020.
-
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study
Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R;(...)Vanderver A; Graus F; Saiz A; Dalmau J; Spanish Pediatric anti-MOG Study Group.Referència:Lancet Neurology 2020.
-
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia
Stein, H; Barbosa, J; Rosa-Justicia, M; Prades, L; Morato, A;(...)Arino, H; Martinez-Hernandez, E; Castro-Fornieles, J; Dalmau, J; Compte, A.Referència:Nature Communications 2020.
-
Characterization of the sleep disorder of anti-IgLON5 disease
Gaig C; Iranzo A; Cajochen C; Vilaseca I; Embid C;Dalmau J; Graus F; Santamaria J .Referència:Sleep 2019.